The Novo Nordisk Foundation's Clinical Emerging Investigator grant supports Danish junior doctors leading innovative clinical and translational research to advance patient care and human health.
Funder: Novo Nordisk Foundation
Due Dates: January 28, 2026 | January 20, 2027
Funding Amounts: Up to DKK 12,500,000 per grant (5-year projects); total call budget up to DKK 50 million; up to four grants awarded.
Summary: Supports Danish clinical research leaders and junior medical doctors to advance innovative clinical and translational medicine projects with direct relevance to patient care and human health.
Key Information: Applicants must be medical doctors in Denmark, in or about to start specialist training, and cannot have completed specialist training at the deadline.
This grant from the Novo Nordisk Foundation is designed to empower emerging clinical research leaders—specifically junior medical doctors in Denmark—to conduct innovative, high-impact projects in clinical and translational medicine. The aim is to bridge clinical practice and research, supporting projects that improve patient care and human health. Supported research fields include, but are not limited to, disease mechanisms, treatment methods, clinical trials, epidemiology, public health, diagnostic methods, and biomedicine. Successful applicants will be able to dedicate significant time to research while maintaining their clinical responsibilities, fostering a strong integration of research and practice.